Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 79 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
781 13.6 months Recurrent Ovarian cancer 2 Hormone
Christie Hospital United Kingdom 9/2005
Treatment Details: Patients: This phase I/II study involved a total of 26 women with recurrent epithelial ovarian cancer. The median age was 63. Treatment: The treatment consisted of two hormone therapy ag
 
782 13.6 months Advanced NSCLC 4 Biologic therapy
Chemotherapy
Yonsei University College of Medicine Korea 7/2012
Treatment Details: Patients: This phase II study involved patients with advanced non-small-cell lung cancer with no prior chemotherapy who were divided into four separate treatment groups. Group A had 37 pat
 
783 13.6 months Advanced breast cancer 4 Chemotherapy
Szpital im. Mikołaja Kopernika Poland 11/2012
Treatment Details: Patients: This phase 2 study involved 38 female advanced breast cancer patients who had previously been treated with vinorelbine. The median patient age was 56 years. Treatment: Patien
 
784 13.6 months Metastatic melanoma 5 Biologic therapy
Peter MacCallum Cancer Centre Australia 2/2014
Treatment Details: Patients: This phase 3 study involved metastatic melanoma patients with a mutation in the BRAF gene who had not received prior treatment. Patients were divided into two treatment groups. Gr
 
785 13.6 months Metastatic, Castration-Resistant Prostate Cancer 5 Chemotherapy
Hormone
Changhai Hospital China 1/2015
Treatment Details: Patients: This study involved metastatic castration-resistant patients who were divided into two separate treatment groups. Group A consisted of 113 patients with a median age of 70.7 year
 
786 13.5 months Malignant peritoneal mesothelioma 5 Biologic therapy
Chemotherapy
The Royal Marsden NHS Foundation United Kingdom 9/2013
Treatment Details: Patients: This phase 2 study involved 82 malignant pleural mesothelioma patients who had not received prior chemotherapy. The median patient age was 55 years and 67.1% were male. Treatm
 
787 13.5 months Metastatic colorectal carcinoma 4 Biologic therapy
Chemotherapy
University Hospital Gasthuisberg Belgium 10/2012
Treatment Details: Patients: This phase 3 study involved metastatic colorectal carcinoma patients who were divided into two separate treatment groups. Group A included 614 patients, 57.5% male, with a median
 
788 13.5 months Metastatic bladder cancer 4 Chemotherapy
University of California, San Francisco United States 12/2012
Treatment Details: Patients: This phase 2 study involved 16 metastatic bladder cancer patients. The median patient age was 68 years and 81% were male. Treatment: Patients were treated with the chemothera
 
789 13.5 months hepatocellular carcinoma (inoperable) Biologic therapy
Pascale National Cancer Institute Italy 5/2004
Treatment Details: Patients: This Phase I/II study involved a total of 19 patients with unresectable hepatocellular carcinoma, 17 men and 2 women. The average age was 64. Sixteen patinets had metastases (sta
 
790 13.5 months Metastatic renal cell carcinoma 4 Immunotherapy
Cleveland Clinic Taussig Cancer Center United States 4/2003
Treatment Details: Patients: This Phase I trial involved 25 patients with metastatic renal cell carcinoma; 18 men and 7 women. The median age was 59. All patients had undergone prior systemic treatments and
 
Page 79 of 187  | Previous Page  | Next Page